Evgen Pharma plc (EVG.L) – BUY*: Further US patent grant | Port Erin Biopharma (PEBI.L): Interim results
29 Mar 2017
Northland Capital Partners Morning Report
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Northland Capital Partners Morning Report
- Published:
29 Mar 2017 -
Author:
Vadim Alexandre -
Pages:
5
Evgen Pharma plc (EVG.L) – BUY*: Further US patent grant | Port Erin Biopharma (PEBI.L): Interim results